EGFR and cancer: A number of cellular processes that contribute to the growth and advancement of cancer cells can be inhibited by luteolin through the reduction in the activity of certain receptor tyrosine kinases (RTKs), including IGFR, EGFR, and ERs, as well as their downstream effector molecules [176].